1. Inactivation of Cancer Mutations Utilizing CRISPR/Cas9. (30th August 2016) Authors: Gebler, Christina; Lohoff, Tim; Paszkowski-Rogacz, Maciej; Mircetic, Jovan; Chakraborty, Debojyoti; Camgoz, Aylin; Hamann, Martin V; Theis, Mirko; Thiede, Christian; Buchholz, Frank Journal: Journal of the National Cancer Institute Issue: Volume 109:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance. Issue 6 (1st June 2013) Authors: Camgoz, Aylin; Gencer, Emel Basak; Ural, Ali Ugur; Baran, Yusuf Journal: Leukemia & lymphoma Issue: Volume 54:Issue 6(2013:Jun.) Page Start: 1279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance. Issue 6 (June 2013) Authors: Camgoz, Aylin; Gencer, Emel Basak; Ural, Ali Ugur; Baran, Yusuf Journal: Leukemia & lymphoma Issue: Volume 54:Issue 6(2013:Jun.) Page Start: 1279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗